Mounjaro (tirzepatide) is prescribed for type 2 diabetes and, for eligible patients, weight management. A Mumsnet discussion about hair loss during treatment raises a concern that can be distressing. Personal accounts can help people describe their experiences, but they cannot establish what caused an individual case.
Is hair loss a known side effect of Mounjaro?
Yes. The UK prescribing information for Mounjaro lists hair loss as a common adverse reaction in weight management. In pooled SURMOUNT-1, SURMOUNT-2 and SURMOUNT-3 weight-management trials, it was reported in 4.9% of people receiving tirzepatide, compared with 1.0% receiving placebo. These are trial results, not a prediction for an individual person.
What might explain hair loss during Mounjaro use?
Noticing hair loss after a dose increase does not, by itself, show that the dose change caused it. The trial figures establish that hair loss was reported during treatment; they do not explain every individual case. A clinician can assess the pattern of shedding and whether other causes need investigation.
Is the hair loss temporary?
The UK prescribing information says the reported events were mostly mild and that most affected trial participants recovered while continuing treatment. That is reassuring, but it does not guarantee recovery or provide a timetable for any individual.
The NHS advises speaking to a pharmacist or doctor if side effects bother you or do not go away, and continuing your medicine unless advised to stop. Discuss concerns with your prescriber before changing your treatment.
For those interested in peptides and related research-use products, Svelta Labs offers detailed educational resources and product information. Visit Svelta Labs to explore more.
Disclaimer: This article is for educational purposes only and does not replace professional medical advice. Research on Mounjaro and its side effects is ongoing, and users should consult healthcare providers regarding any concerns.
Explore more at sveltalabs.com. Join community.sveltalabs.com.
